Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have received a consensus rating of “Buy” from the nine analysts that are presently covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 12-month target pric
Source link